The journey of stem cell transplantation in Bangladesh: a hike to the state of the art with collaboration between DMCH and MGH

Akter, Mafruha; Khan, Mohiuddin Ahmed; Yeh, Albert C.; Spitzer, Thomas R.; Ferdous, Jannatul; Ara, Tasnim; Biswas, Akhil Ranjan; Islam, Nazrul; Khan, Aziz; Nazneen, Humayra; Barron, Anne‐Marie; Erhardt, Emily; Harlow, Jason; Dey, Bimalangshu R.

doi:10.1182/bloodadvances.2017gs101643

Cited by 2 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Over the previous decade, Bangladesh has developed a few HSCT centers, although no MPS-related transplants have been attempted. 20,21 In agreement with the CARE reporting checklist, we present the following case to highlight the challenges of addressing a rare metabolic illness in Bangladesh, enabling clinicians and stakeholders to respond appropriately. 22…”

Section: Introductionmentioning

confidence: 96%

Limited diagnostic facilities impeding the therapeutic approach of Mucopolysaccharidosis in Bangladesh: a case report

Pulock¹,

Pinky

Hasan³

2022

J Int Med Res

View full text Add to dashboard Cite

In resource-constrained settings, mucopolysaccharidosis (MPS) is a rare hereditary metabolic illness that frequently remains undiagnosed. We present a scenario that illustrates the challenges in diagnosing and managing MPS because of test inaccessibility, and we propose potential approaches to minimize the hurdles. We recommend that physicians anticipate a rare genetic disease, such as MPS, based on the clinical history findings from routine radiological investigations. Additionally, stakeholders should perform risk stratification and implement screening tests as soon as possible to ensure that patients are effectively enrolled in treatment programs.

show abstract

Section: Introductionmentioning

confidence: 96%

Limited diagnostic facilities impeding the therapeutic approach of Mucopolysaccharidosis in Bangladesh: a case report

Pulock¹,

Pinky

Hasan³

2022

J Int Med Res

View full text Add to dashboard Cite

show abstract

Long-Term Outcomes of Autologous Hematopoietic Stem Cell Transplant (HSCT) for Multiple Myeloma: While New Horizons Emerge, It Is Still Only a Silver Lining for Resource-Constrained Settings

Banday¹,

Guru²,

Ayub³

et al. 2023

Cureus

View full text Add to dashboard Cite

BackgroundSignificant hurdles impede the optimal implementation of hematopoietic stem cell transplantation (HSCT) in low-middle income countries (LMICs). Herein, we highlight the challenges faced in LMICs while performing HSCT and report the long-term outcomes of patients with newly diagnosed multiple myeloma (MM) who underwent autologous HSCT (AHSCT) at our center. Besides, we provide a comprehensive review of studies reporting long-term outcomes of AHSCT in MM from the Indian subcontinent. MethodologyThis study was conducted at the State Cancer Institute, Sher-i-

show abstract

The journey of stem cell transplantation in Bangladesh: a hike to the state of the art with collaboration between DMCH and MGH

Cited by 2 publications

References 0 publications

Limited diagnostic facilities impeding the therapeutic approach of Mucopolysaccharidosis in Bangladesh: a case report

Limited diagnostic facilities impeding the therapeutic approach of Mucopolysaccharidosis in Bangladesh: a case report

Long-Term Outcomes of Autologous Hematopoietic Stem Cell Transplant (HSCT) for Multiple Myeloma: While New Horizons Emerge, It Is Still Only a Silver Lining for Resource-Constrained Settings

Contact Info

Product

Resources

About